Global Endometriosis Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 278682
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Endometriosis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Endometriosis Drugs market size is estimated to be worth US$ 1909.9 million in 2021 and is forecast to a readjusted size of USD 2246.3 million by 2028 with a CAGR of 2.3% during review period. Hospitals accounting for % of the Endometriosis Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hormonal Therapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Endometriosis Drugs include AbbVie, Astellas Pharma, AstraZeneca, Debiopharm Group, and Evotec, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Endometriosis Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Hormonal Therapy

Add-back Medication

Progestogens

Chinese Herbs

Market segment by Application, can be divided into

Hospitals

Clinics

Research Institutes

Market segment by players, this report covers

AbbVie

Astellas Pharma

AstraZeneca

Debiopharm Group

Evotec

Kissei Pharmaceutical

Neurocrine Biosciences

ObsEva

Pfizer

Repros Therapeutics

Roivant Sciences

Takeda Pharmaceutical Company

ValiRx

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Endometriosis Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Endometriosis Drugs, with revenue, gross margin and global market share of Endometriosis Drugs from 2019 to 2022.

Chapter 3, the Endometriosis Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Endometriosis Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Endometriosis Drugs research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Endometriosis Drugs

1.2 Classification of Endometriosis Drugs by Type

1.2.1 Overview: Global Endometriosis Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Endometriosis Drugs Revenue Market Share by Type in 2021

1.2.3 Hormonal Therapy

1.2.4 Add-back Medication

1.2.5 Progestogens

1.2.6 Chinese Herbs

1.3 Global Endometriosis Drugs Market by Application

1.3.1 Overview: Global Endometriosis Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Institutes

1.4 Global Endometriosis Drugs Market Size & Forecast

1.5 Global Endometriosis Drugs Market Size and Forecast by Region

1.5.1 Global Endometriosis Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Endometriosis Drugs Market Size by Region, (2017-2022)

1.5.3 North America Endometriosis Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Endometriosis Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Endometriosis Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Endometriosis Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Endometriosis Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Endometriosis Drugs Market Drivers

1.6.2 Endometriosis Drugs Market Restraints

1.6.3 Endometriosis Drugs Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 AbbVie

2.1.1 AbbVie Details

2.1.2 AbbVie Major Business

2.1.3 AbbVie Endometriosis Drugs Product and Solutions

2.1.4 AbbVie Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AbbVie Recent Developments and Future Plans

2.2 Astellas Pharma

2.2.1 Astellas Pharma Details

2.2.2 Astellas Pharma Major Business

2.2.3 Astellas Pharma Endometriosis Drugs Product and Solutions

2.2.4 Astellas Pharma Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Astellas Pharma Recent Developments and Future Plans

2.3 AstraZeneca

2.3.1 AstraZeneca Details

2.3.2 AstraZeneca Major Business

2.3.3 AstraZeneca Endometriosis Drugs Product and Solutions

2.3.4 AstraZeneca Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 AstraZeneca Recent Developments and Future Plans

2.4 Debiopharm Group

2.4.1 Debiopharm Group Details

2.4.2 Debiopharm Group Major Business

2.4.3 Debiopharm Group Endometriosis Drugs Product and Solutions

2.4.4 Debiopharm Group Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Debiopharm Group Recent Developments and Future Plans

2.5 Evotec

2.5.1 Evotec Details

2.5.2 Evotec Major Business

2.5.3 Evotec Endometriosis Drugs Product and Solutions

2.5.4 Evotec Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Evotec Recent Developments and Future Plans

2.6 Kissei Pharmaceutical

2.6.1 Kissei Pharmaceutical Details

2.6.2 Kissei Pharmaceutical Major Business

2.6.3 Kissei Pharmaceutical Endometriosis Drugs Product and Solutions

2.6.4 Kissei Pharmaceutical Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Kissei Pharmaceutical Recent Developments and Future Plans

2.7 Neurocrine Biosciences

2.7.1 Neurocrine Biosciences Details

2.7.2 Neurocrine Biosciences Major Business

2.7.3 Neurocrine Biosciences Endometriosis Drugs Product and Solutions

2.7.4 Neurocrine Biosciences Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Neurocrine Biosciences Recent Developments and Future Plans

2.8 ObsEva

2.8.1 ObsEva Details

2.8.2 ObsEva Major Business

2.8.3 ObsEva Endometriosis Drugs Product and Solutions

2.8.4 ObsEva Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 ObsEva Recent Developments and Future Plans

2.9 Pfizer

2.9.1 Pfizer Details

2.9.2 Pfizer Major Business

2.9.3 Pfizer Endometriosis Drugs Product and Solutions

2.9.4 Pfizer Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Pfizer Recent Developments and Future Plans

2.10 Repros Therapeutics

2.10.1 Repros Therapeutics Details

2.10.2 Repros Therapeutics Major Business

2.10.3 Repros Therapeutics Endometriosis Drugs Product and Solutions

2.10.4 Repros Therapeutics Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Repros Therapeutics Recent Developments and Future Plans

2.11 Roivant Sciences

2.11.1 Roivant Sciences Details

2.11.2 Roivant Sciences Major Business

2.11.3 Roivant Sciences Endometriosis Drugs Product and Solutions

2.11.4 Roivant Sciences Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Roivant Sciences Recent Developments and Future Plans

2.12 Takeda Pharmaceutical Company

2.12.1 Takeda Pharmaceutical Company Details

2.12.2 Takeda Pharmaceutical Company Major Business

2.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Product and Solutions

2.12.4 Takeda Pharmaceutical Company Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Takeda Pharmaceutical Company Recent Developments and Future Plans

2.13 ValiRx

2.13.1 ValiRx Details

2.13.2 ValiRx Major Business

2.13.3 ValiRx Endometriosis Drugs Product and Solutions

2.13.4 ValiRx Endometriosis Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 ValiRx Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Endometriosis Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Endometriosis Drugs Players Market Share in 2021

3.2.2 Top 10 Endometriosis Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Endometriosis Drugs Players Head Office, Products and Services Provided

3.4 Endometriosis Drugs Mergers & Acquisitions

3.5 Endometriosis Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Endometriosis Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Endometriosis Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Endometriosis Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Endometriosis Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Endometriosis Drugs Revenue by Type (2017-2028)

6.2 North America Endometriosis Drugs Revenue by Application (2017-2028)

6.3 North America Endometriosis Drugs Market Size by Country

6.3.1 North America Endometriosis Drugs Revenue by Country (2017-2028)

6.3.2 United States Endometriosis Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Endometriosis Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Endometriosis Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Endometriosis Drugs Revenue by Type (2017-2028)

7.2 Europe Endometriosis Drugs Revenue by Application (2017-2028)

7.3 Europe Endometriosis Drugs Market Size by Country

7.3.1 Europe Endometriosis Drugs Revenue by Country (2017-2028)

7.3.2 Germany Endometriosis Drugs Market Size and Forecast (2017-2028)

7.3.3 France Endometriosis Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Endometriosis Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Endometriosis Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Endometriosis Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Endometriosis Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Endometriosis Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Endometriosis Drugs Market Size by Region

8.3.1 Asia-Pacific Endometriosis Drugs Revenue by Region (2017-2028)

8.3.2 China Endometriosis Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Endometriosis Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Endometriosis Drugs Market Size and Forecast (2017-2028)

8.3.5 India Endometriosis Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Endometriosis Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Endometriosis Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Endometriosis Drugs Revenue by Type (2017-2028)

9.2 South America Endometriosis Drugs Revenue by Application (2017-2028)

9.3 South America Endometriosis Drugs Market Size by Country

9.3.1 South America Endometriosis Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Endometriosis Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Endometriosis Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Endometriosis Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Endometriosis Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Endometriosis Drugs Market Size by Country

10.3.1 Middle East & Africa Endometriosis Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Endometriosis Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Endometriosis Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Endometriosis Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Endometriosis Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Endometriosis Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Endometriosis Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Endometriosis Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Endometriosis Drugs Revenue Market Share by Region (2023-2028)

Table 6. AbbVie Corporate Information, Head Office, and Major Competitors

Table 7. AbbVie Major Business

Table 8. AbbVie Endometriosis Drugs Product and Solutions

Table 9. AbbVie Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 11. Astellas Pharma Major Business

Table 12. Astellas Pharma Endometriosis Drugs Product and Solutions

Table 13. Astellas Pharma Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 15. AstraZeneca Major Business

Table 16. AstraZeneca Endometriosis Drugs Product and Solutions

Table 17. AstraZeneca Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Debiopharm Group Corporate Information, Head Office, and Major Competitors

Table 19. Debiopharm Group Major Business

Table 20. Debiopharm Group Endometriosis Drugs Product and Solutions

Table 21. Debiopharm Group Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Evotec Corporate Information, Head Office, and Major Competitors

Table 23. Evotec Major Business

Table 24. Evotec Endometriosis Drugs Product and Solutions

Table 25. Evotec Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Kissei Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 27. Kissei Pharmaceutical Major Business

Table 28. Kissei Pharmaceutical Endometriosis Drugs Product and Solutions

Table 29. Kissei Pharmaceutical Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Neurocrine Biosciences Corporate Information, Head Office, and Major Competitors

Table 31. Neurocrine Biosciences Major Business

Table 32. Neurocrine Biosciences Endometriosis Drugs Product and Solutions

Table 33. Neurocrine Biosciences Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. ObsEva Corporate Information, Head Office, and Major Competitors

Table 35. ObsEva Major Business

Table 36. ObsEva Endometriosis Drugs Product and Solutions

Table 37. ObsEva Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Pfizer Corporate Information, Head Office, and Major Competitors

Table 39. Pfizer Major Business

Table 40. Pfizer Endometriosis Drugs Product and Solutions

Table 41. Pfizer Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Repros Therapeutics Corporate Information, Head Office, and Major Competitors

Table 43. Repros Therapeutics Major Business

Table 44. Repros Therapeutics Endometriosis Drugs Product and Solutions

Table 45. Repros Therapeutics Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Roivant Sciences Corporate Information, Head Office, and Major Competitors

Table 47. Roivant Sciences Major Business

Table 48. Roivant Sciences Endometriosis Drugs Product and Solutions

Table 49. Roivant Sciences Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Takeda Pharmaceutical Company Corporate Information, Head Office, and Major Competitors

Table 51. Takeda Pharmaceutical Company Major Business

Table 52. Takeda Pharmaceutical Company Endometriosis Drugs Product and Solutions

Table 53. Takeda Pharmaceutical Company Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. ValiRx Corporate Information, Head Office, and Major Competitors

Table 55. ValiRx Major Business

Table 56. ValiRx Endometriosis Drugs Product and Solutions

Table 57. ValiRx Endometriosis Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Endometriosis Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Endometriosis Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Endometriosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Endometriosis Drugs Players Head Office, Products and Services Provided

Table 62. Endometriosis Drugs Mergers & Acquisitions in the Past Five Years

Table 63. Endometriosis Drugs New Entrants and Expansion Plans

Table 64. Global Endometriosis Drugs Revenue (USD Million) by Type (2017-2022)

Table 65. Global Endometriosis Drugs Revenue Share by Type (2017-2022)

Table 66. Global Endometriosis Drugs Revenue Forecast by Type (2023-2028)

Table 67. Global Endometriosis Drugs Revenue by Application (2017-2022)

Table 68. Global Endometriosis Drugs Revenue Forecast by Application (2023-2028)

Table 69. North America Endometriosis Drugs Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Endometriosis Drugs Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Endometriosis Drugs Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Endometriosis Drugs Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Endometriosis Drugs Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Endometriosis Drugs Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Endometriosis Drugs Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Endometriosis Drugs Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Endometriosis Drugs Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Endometriosis Drugs Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Endometriosis Drugs Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Endometriosis Drugs Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Endometriosis Drugs Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Endometriosis Drugs Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Endometriosis Drugs Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Endometriosis Drugs Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Endometriosis Drugs Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Endometriosis Drugs Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Endometriosis Drugs Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Endometriosis Drugs Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Endometriosis Drugs Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Endometriosis Drugs Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Endometriosis Drugs Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Endometriosis Drugs Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Endometriosis Drugs Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Endometriosis Drugs Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Endometriosis Drugs Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Endometriosis Drugs Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Endometriosis Drugs Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Endometriosis Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Endometriosis Drugs Picture

Figure 2. Global Endometriosis Drugs Revenue Market Share by Type in 2021

Figure 3. Hormonal Therapy

Figure 4. Add-back Medication

Figure 5. Progestogens

Figure 6. Chinese Herbs

Figure 7. Endometriosis Drugs Revenue Market Share by Application in 2021

Figure 8. Hospitals Picture

Figure 9. Clinics Picture

Figure 10. Research Institutes Picture

Figure 11. Global Endometriosis Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Endometriosis Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Endometriosis Drugs Revenue Market Share by Region (2017-2028)

Figure 14. Global Endometriosis Drugs Revenue Market Share by Region in 2021

Figure 15. North America Endometriosis Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Endometriosis Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Endometriosis Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Endometriosis Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Endometriosis Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Endometriosis Drugs Market Drivers

Figure 21. Endometriosis Drugs Market Restraints

Figure 22. Endometriosis Drugs Market Trends

Figure 23. AbbVie Recent Developments and Future Plans

Figure 24. Astellas Pharma Recent Developments and Future Plans

Figure 25. AstraZeneca Recent Developments and Future Plans

Figure 26. Debiopharm Group Recent Developments and Future Plans

Figure 27. Evotec Recent Developments and Future Plans

Figure 28. Kissei Pharmaceutical Recent Developments and Future Plans

Figure 29. Neurocrine Biosciences Recent Developments and Future Plans

Figure 30. ObsEva Recent Developments and Future Plans

Figure 31. Pfizer Recent Developments and Future Plans

Figure 32. Repros Therapeutics Recent Developments and Future Plans

Figure 33. Roivant Sciences Recent Developments and Future Plans

Figure 34. Takeda Pharmaceutical Company Recent Developments and Future Plans

Figure 35. ValiRx Recent Developments and Future Plans

Figure 36. Global Endometriosis Drugs Revenue Share by Players in 2021

Figure 37. Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Endometriosis Drugs Revenue Market Share in 2021

Figure 39. Global Top 10 Players Endometriosis Drugs Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Endometriosis Drugs Revenue Share by Type in 2021

Figure 42. Global Endometriosis Drugs Market Share Forecast by Type (2023-2028)

Figure 43. Global Endometriosis Drugs Revenue Share by Application in 2021

Figure 44. Global Endometriosis Drugs Market Share Forecast by Application (2023-2028)

Figure 45. North America Endometriosis Drugs Sales Market Share by Type (2017-2028)

Figure 46. North America Endometriosis Drugs Sales Market Share by Application (2017-2028)

Figure 47. North America Endometriosis Drugs Revenue Market Share by Country (2017-2028)

Figure 48. United States Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Endometriosis Drugs Sales Market Share by Type (2017-2028)

Figure 52. Europe Endometriosis Drugs Sales Market Share by Application (2017-2028)

Figure 53. Europe Endometriosis Drugs Revenue Market Share by Country (2017-2028)

Figure 54. Germany Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Endometriosis Drugs Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Endometriosis Drugs Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Endometriosis Drugs Revenue Market Share by Region (2017-2028)

Figure 62. China Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Endometriosis Drugs Sales Market Share by Type (2017-2028)

Figure 69. South America Endometriosis Drugs Sales Market Share by Application (2017-2028)

Figure 70. South America Endometriosis Drugs Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Endometriosis Drugs Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Endometriosis Drugs Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Endometriosis Drugs Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Endometriosis Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz